Skip to content
Oncology Research Hub

Fairfax, Virginia

Cancer clinical trials in Fairfax, VA

238 cancer studies are recruiting participants at sites in Fairfax as of November 16, 2026, according to ClinicalTrials.gov. Oncology Research Hub can help you understand your options and connect with a study team.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Fairfax at a glance

  • 238 studies are recruiting at a site in Fairfax.
  • By phase: Phase 1 (71), Phase 1/2 (78), Phase 2 (29), Phase 2/3 (6), Phase 3 (47), Phase 4 (1), No phase (3), Observational (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (218), university, hospital or other (17), government (3).
  • By research area: Lung Cancer (116), Breast Cancer (75), Prostate Cancer (15), Pancreatic Cancer (14), Lymphoma (12), Melanoma (6).
  • Most recent update to one of these records: November 16, 2026.

Breast cancer studies recruiting in Fairfax

Basic details from each study's public record (the 30 most recently updated of 238). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study sites
    Inova Schar Cancer Institute · Virginia Cancer Specialists, PC
    Registry record
    NCT06324357 · updated
  2. Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Inova Schar Cancer Institute ( Site 0051)
    Registry record
    NCT06686394 · updated
  3. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Inova Schar Cancer Institute Clinical Trials
    Registry record
    NCT07488676 · updated
  4. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Inova Schar Cancer Institute
    Registry record
    NCT05564377 · updated
  5. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study sites
    Inova Schar Cancer Institute · NEXT Virginia
    Registry record
    NCT06270706 · updated
  6. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT06638307 · updated
  7. A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Prelude Therapeutics Incorporated
    Study site
    NEXT Virginia
    Registry record
    NCT07905001 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Fairfax, VA on ClinicalTrials.gov.

Lung cancer studies recruiting in Fairfax

  1. Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Teligene US
    Study site
    Virginia Cancer Specialists
    Registry record
    NCT05168566 · updated
  2. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Tyligand Pharmaceuticals (Suzhou) Limited
    Study site
    NEXT Virginia
    Registry record
    NCT06385925 · updated
  3. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT06983743 · updated
  4. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    NEXT Oncology Virginia
    Registry record
    NCT07277413 · updated
  5. A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Eikon Therapeutics
    Study site
    Virginia Cancer Specialists, PC
    Registry record
    NCT07365319 · updated
  6. A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT07730021 · updated
  7. Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Virginia Cancer Specialists (VCS) ( Site 0408)
    Registry record
    NCT06780098 · updated
  8. A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    NEXT Virginia
    Registry record
    NCT07111520 · updated
  9. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Virginia Cancer Specialists
    Registry record
    NCT07659782 · updated
  10. Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

    • Observational
    • All ages
    • All sexes
    Sponsor
    Lung Cancer Mutation Consortium
    Study site
    Virginia Cancer Specialists, PC
    Registry record
    NCT04712877 · updated
  11. Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study site
    Virginia Cancer Specialists, PC
    Registry record
    NCT04886804 · updated
  12. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    NEXT Oncology Virginia
    Registry record
    NCT07080242 · updated
  13. A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Virginia Cancer Specialists ( Site 0003)
    Registry record
    NCT07221474 · updated
  14. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT07458347 · updated
  15. A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Virginia Cancer Specialists ( Site 0114)
    Registry record
    NCT07554339 · updated
  16. BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    Virginia Cancer Specialists
    Registry record
    NCT07625644 · updated
  17. A KRAS Inhibitor in Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Ensem Therapeutics
    Registry record
    NCT07912593 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Fairfax, VA on ClinicalTrials.gov.

Prostate cancer studies recruiting in Fairfax

  1. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Amgen
    Study site
    Virginia Cancer Specialists PC
    Registry record
    NCT04221542 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Fairfax, VA on ClinicalTrials.gov.

Melanoma studies recruiting in Fairfax

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study sites
    Inova Fair Oaks Hospital · Inova Schar Cancer Institute
    Registry record
    NCT05136196 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Fairfax, VA on ClinicalTrials.gov.

Lymphoma studies recruiting in Fairfax

  1. Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Virginia Cancer Specialists, PC
    Registry record
    NCT06806033 · updated
  2. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Study site
    Virginia Cancer Specialists, PC
    Registry record
    NCT07221500 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Fairfax, VA on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Fairfax

  1. A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study sites
    Investigative Site US057 · Investigative Site US065
    Registry record
    NCT07522073 · updated
  2. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Virginia Cancer Specialists
    Registry record
    NCT07644559 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Fairfax, VA on ClinicalTrials.gov.

Ask about studies near Fairfax

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Virginia

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call